Sort
53,477 grants matching “addiction”
Structural basis for the functions of dopamine receptors, neurotransmitter transporters, and sigma 1 receptor
$2,628,749Lei Shi · National Institute On Drug Abuse · ZIA · FY2024 · DA
Center for Methodologies for Adapting and Personalizing Prevention, Treatment and Recovery Services for SUD and HIV (MAPS Center)
$2,623,791Inbal Billie Nahum-Shani · University Of Michigan At Ann Arbor · P50 · FY2022 · DA
Hypothalamic neuronal circuits controlling survival behaviors
$2,621,754Yeka Aponte · National Institute On Drug Abuse · ZIA · FY2024 · DA
Basic and Translational Research Center for Reducing Health Disparities
$2,619,752Jesus Alexander Angulo · Hunter College · G12 · FY2016 · MD
Integrated GWAS of complex behavioral and gene expression traits in outbred rats
$2,618,934Abraham A Palmer · University Of Chicago · P50 · FY2014 · DA
The National Drug Abuse Treatment Clinical Trials Network
$2,614,624Walter Nmn Ling · University Of California Los Angeles · U10 · FY2014 · DA
Evaluating New Nicotine Standards for Cigarettes
$2,612,355Eric Christian Donny · University Of Pittsburgh At Pittsburgh · U54 · FY2012 · DA
Basic and Translational Research Center for Reducing Health Disparities
$2,610,673Jesus Alexander Angulo · Hunter College · G12 · FY2012 · MD
Single Cell Transcriptomic and Epigenomic Dissection of Opioid and Cocaine Responses in HIV
$2,610,459Manolis Kellis · Broad Institute, Inc. · U01 · FY2024 · DA
Single Cell Transcriptomic and Epigenomic Dissection of Opioid and Cocaine Responses in HIV
$2,610,459Manolis Kellis · Broad Institute, Inc. · U01 · FY2025 · DA
Illuminating neural coding mechanisms using in vivo calcium imaging in freely behaving rodents
$2,609,232Da-Ting Lin · National Institute On Drug Abuse · ZIA · FY2025 · DA
Combination Therapies to Defeat Melanoma Resistance
$2,608,967Antoni Ribas · University Of California Los Angeles · P01 · FY2021 · CA
Synaptic mechanisms underlying reward seeking and compulsive drug use
$2,607,451Veronica A Alvarez · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2021 · AA
Chicago WIHS Consortium V (CWC)
$2,602,457Mardge H Cohen · Hektoen Institute For Medical Research · U01 · FY2015 · AI
Treatment for Complex Patients: Continuing and Extended Care
$2,601,508Joseph R Guydish · University Of California, San Francisco · P50 · FY2013 · DA
Video-Telecare Collaborative Pain Management to Improve Function and Reduce Opioid Risk in Patients with End Stage Renal Disease Receiving Hemodialysis
$2,601,322William C Becker · Yale University · U01 · FY2019 · DK
SPORE in Lung Cancer
$2,599,687University Of Texas Sw Med Ctr/Dallas · P50 · FY2005 · CA
Clinical Genomics and Experimental Therapeutics
$2,598,686Falk Lohoff · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2017 · AA
23/24 Healthy Brain and Child Development National Consortium
$2,598,227Cynthia Elise Rogers · Washington University · U01 · FY2024 · DA
Neuroimaging of preclinical models of substance use disorders
$2,598,064Yihong Yang · National Institute On Drug Abuse · ZIA · FY2022 · DA
Thalamocortical Responsive Neurostimulation for the Treatment of Lennox-Gastaut Syndrome
$2,596,763Martha J Morrell · Neuropace, Inc. · UH3 · FY2022 · NS
The Florida Node Alliance of the National Drug Abuse Treatment Clinical Trials Network
$2,596,126Jose Szapocznik · University Of Miami School Of Medicine · UG1 · FY2016 · DA
Novel Therapeutics for Opioid Use Disorder in the Acute Overdose and Maintenance Settings
$2,594,546Donald R Gehlert · Epiodyne, Inc. · UH3 · FY2022 · DA
FKBP51 antagonism to prevent chronic pain: optimizing efficacy & evaluating safety and mechanisms
$2,589,652Sarah Linnstaedt · Univ Of North Carolina Chapel Hill · R01 · FY2020 · NS
Efficacy of a Nicotine Vaccine for Smoking Cessation
$2,588,831Nabi Biopharmaceuticals · R01 · FY2005 · DA